Tenaya Therapeutics, Inc.
TNYA
$1.26
-$0.17-11.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.28M | -26.86M | -23.84M | -25.63M | -29.43M |
| Total Depreciation and Amortization | 2.08M | 2.66M | 2.09M | 2.10M | 2.12M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.58M | 4.53M | 4.40M | 5.01M | 5.63M |
| Change in Net Operating Assets | 1.01M | -3.44M | -1.04M | -1.32M | -1.94M |
| Cash from Operations | -15.61M | -23.11M | -18.39M | -19.84M | -23.62M |
| Capital Expenditure | -142.00K | -383.00K | -204.00K | -184.00K | -73.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.13M | 22.69M | 14.31M | -29.91M | 21.69M |
| Cash from Investing | 24.99M | 22.30M | 14.10M | -30.10M | 21.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 50.26M | 377.00K | 31.00K | 570.00K |
| Repurchase of Common Stock | -476.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -476.00K | 50.26M | 377.00K | 31.00K | 570.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.90M | 49.45M | -3.91M | -49.90M | -1.43M |